Alatau: Biopharmaceutical Complex with 103 Billion Tenge Investment Volume

Investment & companiesGolden2 Sources

Published 11 Nov 2026 · last updated 11 Nov 2026 · 1 Jan 2026 – 2 Jan 2026

A biopharmaceutical complex with an investment volume of over 103 billion tenge is being built in the Special Economic Zone Alatau. The project is implemented by the Ministry of Health of Kazakhstan and Khan Tengri Biopharma. The plan includes the production of 58 preparations, including active ingredients for oncology and rare diseases.

District: Golden (derived from the type of project)

Key facts

• Investment volume: over 103 billion tenge.
• Implementation by the Ministry of Health of RK and TOO Khan Tengri Biopharma.
• Production scope: 58 preparations, including 27 international non-proprietary names.
• Goal: Reduce import dependency and increase domestic share to 50 %.

All sources (2)

1. В Казахстане вложат более 103 млрд ₸ в биофармацевтику полного цикла24.kz (Telegram) · 1 Jan 2026 · RU
2. В Алатау построят крупный биофармацевтический комплексVlast.kz (Telegram) · 2 Jan 2026 · RU